Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael KilbyStudy Chair
- Ronald MitsuyasuStudy Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Puerto Rico-Aids Crs
San Juan, Puerto Rico
- Alabama Therapeutics Crs
Birmingham, Alabama, United States
- Ucla Care Center Crs
Los Angeles, California, United States
- Usc Crs
Los Angeles, California, United States
- Stanford Crs
Palo Alto, California, United States
- Ucsf Aids Crs
San Francisco, California, United States
- Santa Clara Valley Med. Ctr.
San Jose, California, United States
- San Mateo County Aids Program
San Mateo, California, United States
- Marin County Dept. of Health & Human Services, Hiv/aids Program & Specialty Clinic
San Rafael, California, United States
- Harbor-Ucla Med. Ctr. Crs
Torrance, California, United States
- University of Colorado Hospital Crs
Aurora, Colorado, United States
- Univ. of Miami Aids Crs
Miami, Florida, United States
- the Ponce de Leon Ctr. Crs
Atlanta, Georgia, United States
- Univ. of Hawaii at Manoa, Leahi Hosp.
Honolulu, Hawaii, United States
- Northwestern University Crs
Chicago, Illinois, United States
- Indiana Univ. School of Medicine, Infectious Disease Research Clinic
Indianapolis, Indiana, United States
- Indiana Univ. School of Medicine, Wishard Memorial
Indianapolis, Indiana, United States
- Methodist Hosp. of Indiana
Indianapolis, Indiana, United States
- University of Minnesota, Actu
Minneapolis, Minnesota, United States
- Beth Israel Med. Ctr., Actu
New York, New York, United States
- Ny Univ. Hiv/aids Crs
New York, New York, United States
- Univ. of Rochester Actg Crs
Rochester, New York, United States
- Unc Aids Crs
Chapel Hill, North Carolina, United States
- Hosp. of the Univ. of Pennsylvania Crs
Philadelphia, Pennsylvania, United States
- Vanderbilt Therapeutics Crs
Nashville, Tennessee, United States
- Univ. of Texas Medical Branch, Actu
Galveston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- 31 Oct 2005
- Last update posted
- 1 Nov 2021
- Registered enrollment
- 100
- Registry id
- NCT00006291
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.